Evidence map›Paper›PMID 26688181›Full record

ReviewChinese journal of integrative medicine2016

Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy.

Lei Zhang, La Zhang, Yin Li, Xin-Feng Guo, Xu-Sheng Liu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Chinese journal of integrative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lei ZhangDepartment of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
La ZhangGuangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Yin LiGuangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Xin-Feng GuoEvidence-Based Medicine and Clinical Research Service Team, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China. drguoguo@gmail.com.
Xu-Sheng LiuDepartment of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China. liuxu801@126.com.
Guangdong Provincial Hospital of Traditional Chinese Medicine · CNGuangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compared with herbal drugs, medicine processed from animals (animal medicine) was thought to have more bioactive substances and higher activities. Biotransformation effect often plays an important role in their effect. However, researches about effect of animal medicine on diabetic nephropathy and applying animal medicine as natural bio-transformer were seldom reported. The purpose of this paper was to reveal the use of Bombyx Mori L. on diabetic nephropathy from ancient to modern times. The classical literature indicated that Saosi Decoction (), which contains Bombyx Mori L. or silkworm cocoon, was applied to treat disorders congruent with modern disease diabetic nephropathy from the Ming to Qing Dynasty in ancient China. Modern studies showed that Bombyx Mori L. contains four main active constituents. Among these, 1-deoxynojirimycin (1-DNJ) and quercetin showed promising potential to be new agents in diabetic nephropathy treatment. The concentrations of 1-DNJ and the activities of quercetin in Bombyx Mori L. are higher than in mulberry leaves, because of the biotransformation in the Bombyx Mori L. body. However, these specifific components need further human and mechanistic studies to determine their therapeutic potential for this challenging condition.

Indexed as

AnimalsBiological ProductsBiotransformationBombyxDiabetic NephropathiesMedicine, Chinese TraditionalBiological Products1-deoxynojirimycinbiotransformationBombyx Mori L.Chinese medicinediabetic nephropathyquercetin

Identifiers

PMID26688181
OpenAlexW2475350136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.